Shandong Sito Bio-technology Co Ltd (300583) — Capital Reinvestment Ratio

Latest as of September 2025: 0.71x

Shandong Sito Bio-technology Co Ltd (300583) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.13 Million) in capital expenditures (CN¥10.75 Million). See Shandong Sito Bio-technology Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.71x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥15.13 Million
CNY

Capital Expenditures

CN¥10.75 Million
CNY

Data as of

Sep 2025
Most recent filing

Shandong Sito Bio-technology Co Ltd Capital Reinvestment Ratio (2013–2024)

This chart tracks Shandong Sito Bio-technology Co Ltd's Capital Reinvestment Ratio across 10 annual periods.

Annual Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd (2013–2024)

Year-by-year Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see 300583 market cap.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.34x CN¥194.46 Million CN¥65.53 Million ▼ -65.9%
2022 0.99x CN¥145.34 Million CN¥143.68 Million ▼ -42.2%
2021 1.71x CN¥227.35 Million CN¥388.92 Million ▲ +79.5%
2020 0.95x CN¥254.60 Million CN¥242.60 Million ▼ -73.9%
2019 3.66x CN¥57.62 Million CN¥210.73 Million ▼ -47.1%
2017 6.91x CN¥10.90 Million CN¥75.34 Million ▲ +340.3%
2016 1.57x CN¥80.15 Million CN¥125.87 Million ▲ +4.7%
2015 1.50x CN¥87.10 Million CN¥130.67 Million ▲ +14.1%
2014 1.31x CN¥174.49 Million CN¥229.42 Million ▼ -29.5%
2013 1.87x CN¥24.95 Million CN¥46.55 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow